Carboline Isomer Diversity and Heterodimer Design: A New Frontier in Drug Discovery.

Natural product-derived heterocyclic scaffolds remain indispensable in medicinal chemistry because of their structural diversity and broad therapeutic potential. Among them, carbolines have emerged as privileged pharmacophores exhibiting anticancer, antimicrobial, antiviral, anti-inflammatory, antiparasitic, and neuroprotective activities. Despite the existence of four distinct carboline isoforms (α-, β-, γ-, and δ-carbolines), research has been disproportionately focused on β-carbolines, whereas the remaining isoforms remain comparatively underexplored. Moreover, current medicinal chemistry strategies have primarily relied on scaffold functionalization and design of homodimeric carbolines, leaving a substantial portion of the accessible isomer-pairing and linkage space unexplored. From this perspective, we reviewed the pharmacological breadth of the four carboline isoforms but shifted the principal emphasis toward what homodimeric and bivalent carboline precedents can teach us about future heterodimer design. We specifically examined isomer-pair selection, attachment topology, linker length and composition, general synthetic routes, prospective structure-activity relationships, physicochemical liabilities, and matched control experiments to determine whether heterodimerization confers a real advantage over the corresponding monomers and homodimers. Rather than assuming enhanced potency or multitarget activity, heterodimerization is treated as an experimentally testable medicinal chemistry hypothesis. Finally, we discussed key challenges and outlined a practical discovery workflow for converting this design space into a validated lead series.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-11-17
DOI
https://doi.org/10.2174/0109298673535544261116060641
Primary Topic
Synthesis and bioactivity of alkaloids
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Carboline Isomer Diversity and Heterodimer Design: A New Frontier in Drug Discovery.

Sihui Long, Muneeb Ur Rehman, Munazza Yazdani
PubMed
Synthesis and bioactivity of alkaloids
article

Carboline Isomer Diversity and Heterodimer Design: A New Frontier in Drug Discovery.

Sihui Long, Muneeb Ur Rehman, Munazza Yazdani
article en

Abstract

Natural product-derived heterocyclic scaffolds remain indispensable in medicinal chemistry because of their structural diversity and broad therapeutic potential. Among them, carbolines have emerged as privileged pharmacophores exhibiting anticancer, antimicrobial, antiviral, anti-inflammatory, antiparasitic, and neuroprotective activities. Despite the existence of four distinct carboline isoforms (α-, β-, γ-, and δ-carbolines), research has been disproportionately focused on β-carbolines, whereas the remaining isoforms remain comparatively underexplored. Moreover, current medicinal chemistry strategies have primarily relied on scaffold functionalization and design of homodimeric carbolines, leaving a substantial portion of the accessible isomer-pairing and linkage space unexplored. From this perspective, we reviewed the pharmacological breadth of the four carboline isoforms but shifted the principal emphasis toward what homodimeric and bivalent carboline precedents can teach us about future heterodimer design. We specifically examined isomer-pair selection, attachment topology, linker length and composition, general synthetic routes, prospective structure-activity relationships, physicochemical liabilities, and matched control experiments to determine whether heterodimerization confers a real advantage over the corresponding monomers and homodimers. Rather than assuming enhanced potency or multitarget activity, heterodimerization is treated as an experimentally testable medicinal chemistry hypothesis. Finally, we discussed key challenges and outlined a practical discovery workflow for converting this design space into a validated lead series.

PubMed
Wuhan Institute of Technology (CN)
Synthesis and bioactivity of alkaloids
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon